Smart Holistic Health Care Platform for families of children with cancer
Official title: Efficacy of a Smart Holistic Health Care Platform Intervention on Cancer Children and Parents' Bio-Psycho-Social and Spiritual Health: A Multiple-Site Randomized Control Trial
Run by National Defense Medical Center, Taiwan · NCT07805096 · Data updated 2026-11-12
Aims to see if two smart platforms for parents and children with leukemia or brain tumors in Taiwan can improve quality of life and overall well-being during treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 7 Years and up |
| Sex | All |
| Enrollment | 120 (estimated) |
| Sponsor | National Defense Medical Center, Taiwan Academic / other |
| Locations | 1 site (Taipei) |
| Status | Recruiting |
| Started | December 30, 2025 |
| Main results expected | July 30, 2028 |
| Study ends | August 30, 2028 |
| Registry record updated | September 4, 2026 |
| Trial ID | NCT07805096 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Parents who are primary caregivers of a child (2–18 years) with leukemia or a brain tumor, able to access the Internet and use Chinese-language digital tools; children aged 7–18 with leukemia or a brain tumor, able to use a smartphone/tablet.
✕Probably not a fit
Participants with unstable disease, cognitive impairment, or those already using another smart health care platform may see limited benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter trial tests two digital platforms, one for parents and one for children, designed to support physical, psychological, social, and spiritual needs during pediatric cancer treatment. Participants are families of children aged 2–18 with leukemia or brain tumors, recruited from four northern Taiwan centers. Families are randomized to receive the SHHCP intervention or usual care, with outcomes measured at baseline, 2, 5, and 8 months. The study focuses on fatigue, quality of life, anxiety, resilience, post-traumatic growth, parenting self-efficacy, spiritual well-being for parents, and cancer-related fatigue and pediatric quality of life for children.
Why it matters
Potential benefit: If successful, the platforms could enhance family communication with clinicians and improve holistic well-being for both children and their parents during cancer treatment.
How similar studies have gone: Previous digital health and family-centered interventions in pediatric populations have shown improvements in QoL and psychosocial outcomes, but this SHHCP approach is novel in combining parent and child platforms for this specific cancer mix.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: Parents: Parent of a child diagnosed with leukemia or a brain tumor. The child is between 2 and 18 years of age. The parent is the primary caregiver of the child, agrees to participate in the study, and is willing to complete self-administered questionnaires. Able to speak, understand, read, and write Chinese. Has access to the Internet. Has no cognitive impairment. Has not previously participated in another study involving a smart health care platform. Is not taking medications that may affect fatigue, anxiety, mood, or behavior. Children: Diagnosed with leukemia or a brain tumor. Between 7 and 18 years of age. Is not taking medications that may affect fatigue, anxiety, mood, or behavior. Able to communicate in Chinese. Has no cognitive impairment. Able to use a smartphone or tablet independently or with assistance from a caregiver. Will not participate in another smart health care platform study during the study period. Has a stable disease condition and emotional status. Exclusion Criteria: Parents: The child has not been diagnosed with leukemia or a brain tumor. The parent is not the primary caregiver of the child or is unwilling to participate in the study and complete the study questionnaires. Unable to speak, understand, read, or write Chinese. Does not have access to the Internet. Has cognitive impairment. Has previously participated in another study involving a smart health care platform. Is taking medications that may affect fatigue, anxiety, mood, or behavior. Children: Has a psychiatric disorder, such as schizophrenia, depression, or bipolar disorder, or has cognitive impairment or a sleep disorder. Has a congenital disease or congenital anomaly. Has a severe medical condition requiring treatment, such as a severe infection. Has terminal-stage cancer with multiple complications.
Where it's running
-
National Taiwan University Children's Hospital
Taipei, Taiwan Recruiting
Study contacts
- Study coordinator: Jen-Jiuan Liaw, PhD
- Email: jiuanliaw@gmail.com
- Phone: +886-2-87923100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Spectral Precise Image study for brain tumors
Researchers will test the image quality and diagnostic confidence of Spectral Precise Image reconstructions from spectral CT scans in adults with brain tumors.
-
rTMS to improve movement after brain tumor surgery
This pilot will try whether short courses of daily TMS can help adults with new or ongoing movement weakness after brain tumor surgery recover strength and function.
-
Symptom patterns and gut bacteria in childhood cancer survivors
This project will test whether groups of ongoing symptoms in childhood cancer survivors are linked to differences in gut bacteria and their metabolites.
-
Early post-operative brain PET-MRI in glioblastoma surgery
This study tests whether doing PET-MRI soon after glioblastoma surgery is safe and feasible and whether imaging with 18F-DOPA can better detect residual tumor than standard MRI.
-
Vision-language AI to diagnose brain diseases from imaging and clinical data
This project will test a new AI that reads scans, pathology, genomics, and clinical records to help diagnose a wide range of brain diseases for patients with tumors, vascular problems, or neurodegeneration.
-
Improving care pathways for patients with rare brain tumors using AI
This study is testing whether using AI to improve treatment plans can help people with rare brain tumors have better care and quality of life through a home rehabilitation program.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.